| Patient | Frederick Cook |
|---|---|
| Date of birth | 1961-06-10 |
| Identifiers | MRN HR-EX006-SYN; SSN (made up) 000-06-4471 |
| Document date | 2026-07-21 |
| Author | Harriet Okafor-Brandt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week follow-up of high blood pressure and a right carotid bruit, with carotid duplex ultrasound and vascular neurology consultation today. [S]
Mr. Cook returns two weeks after his first visit, on the day of his carotid duplex ultrasound and his consultation with Dr. Abernathy-Mensah. He measured his blood pressure at home twice a day for seven days with the upper-arm cuff from the clinic; the fourteen readings average 154/90. He has had no headache, chest pain, breathlessness, weakness, numbness, speech trouble or loss of vision in either eye. He has cut down on salt and walks each day. He has signed the request for his prison medical records, which have not yet arrived, and has met the social worker once. He feels low at times and ashamed when people recognize his name, but he is sleeping and writing. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Fourteen readings over seven days, average 154/90 |
| Symptoms | None; no stroke or eye symptoms |
| Lifestyle | Less salt; daily walking |
| Records | Prison medical records requested, not yet received |
| Mood | Low at times; ashamed when recognized; sleeping and writing |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No weakness, numbness, speech trouble, or dizziness |
| Eyes | Negative | No transient loss of vision in either eye |
| Psychiatric | Positive | Low at times and ashamed when recognized; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morning | once daily in the morning | Oral route | 2026-07-21 to 2026-09-29 | completed | S |
| Amlodipine 5 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-07-21 | active | S |
| Atorvastatin 40 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-07-21 | active | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | once daily | Oral route | 2026-07-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-21 | Body height | 175 | cm | S |
| 2026-07-21 | Body weight | 75.8 | kg | S |
| 2026-07-21 | Body mass index (BMI) [Ratio] | 24.8 | kg/m2 | S |
| 2026-07-21 | Systolic blood pressure | 158 | mm[Hg] | S |
| 2026-07-21 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 2026-07-21 | Heart rate | 72 | /min | S |
| 2026-07-21 | Respiratory rate | 14 | /min | S |
| 2026-07-21 | Body temperature | 36.5 | Cel | S |
| 2026-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Vital signs recorded on 2026-07-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 158/92, pulse 72, weight 75.8 kg |
| Neck | Soft right carotid bruit; no left bruit |
| Eyes | Fundi: mild arteriolar narrowing; no hemorrhages, exudates or papilledema |
| Cardiovascular | Regular rhythm; no murmur; radial, femoral and foot pulses normal and equal |
| Neurological | Alert and fluent; no facial asymmetry, drift, weakness or sensory loss |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at the first visit, 166/94 mmHg (average of two seated readings), without a previous diagnosis of hypertension; no symptoms; out-of-office confirmation with a week of home readings requested | resolved | confirmed | R03.0 | S — Synthetic presenting finding at re-entry; superseded by the diagnosis at the second visit. |
| Essential hypertension, stage 2, confirmed by home readings averaging 154/90 mmHg; no left ventricular hypertrophy on ECG; urine albumin normal | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. |
| Right carotid bruit heard at the first visit in a man with no symptoms of stroke or transient ischemic attack; carotid duplex ultrasound and vascular neurology consultation requested | resolved | confirmed | R09.89 | S — Synthetic examination finding; superseded by the duplex result at the second visit. |
| Asymptomatic atherosclerotic stenosis of the right internal carotid artery, 50 to 69 percent by duplex ultrasound, with less than 50 percent plaque on the left; no stroke or transient ischemic attack; managed with best medical therapy (blood pressure control, a statin and low-dose aspirin) and yearly duplex surveillance | active | confirmed | I65.21 | S — Synthetic modern diagnosis made at the vascular neurology consultation; not a claim about his real arteries. |
| Recent release from about six years of incarceration: re-entering community life on parole at 65, establishing primary care with no medical records yet received, a rented room, no earned income, and a public reputation he feels as a burden | active | confirmed | Z65.2 | S — Synthetic modern social problem anchored to his documented imprisonment and parole. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, seated, average of two readings | Every visit | Completed today | 158/92 mmHg |
| Self-management | Home blood pressure monitoring | At diagnosis and after each treatment change | Completed today | Average 154/90 over seven days; confirms hypertension |
| Laboratory | Sodium, potassium, creatinine and eGFR | Baseline; early after starting a diuretic or an ARB; then every 6 months | Up to date | Baseline at intake: sodium 140, potassium 4.2 mmol/L, creatinine 0.98 mg/dL, eGFR 86; repeat ordered for about four weeks after starting hydrochlorothiazide |
| Laboratory | Lipid panel | Baseline; 4 to 12 weeks after starting a statin; then every 3 to 12 months | Up to date | Baseline at intake: total cholesterol 228, HDL 46, LDL 148, triglycerides 170 mg/dL; repeat ordered for 4 to 12 weeks after starting atorvastatin |
| Laboratory | ALT on a statin | Baseline, then with the first lipid check or with symptoms | Up to date | Baseline at intake 22 U/L |
| Laboratory | HbA1c or fasting glucose | Annually | Up to date | HbA1c 5.5% and fasting glucose 94 mg/dL at intake |
| Laboratory | Urine albumin-to-creatinine ratio | Annually | Up to date | 18 mg/g at intake |
| Laboratory | TSH | At diagnosis | Up to date | 2.1 mIU/L at intake |
| Imaging | 12-lead ECG | At diagnosis | Up to date | At intake: sinus rhythm, no left ventricular hypertrophy |
| Imaging | Echocardiogram | At diagnosis of stage 2 hypertension | Ordered | Ordered today for stage 2 hypertension |
| Examination | Fundoscopic examination | Annually | Completed today | Mild arteriolar narrowing; no hemorrhages or papilledema |
| Examination | Peripheral pulses and ankle-brachial index | Every 2 to 3 years at 65 or older | Completed today | Pulses normal and equal; no claudication. Ankle-brachial index due at the annual wellness visit |
| Imaging | Carotid duplex ultrasound for known 50 percent or greater stenosis on medical therapy | At diagnosis, then yearly | Completed today | Right internal carotid 50 to 69 percent, left below 50 percent |
| Referral | Vascular neurology consultation | Once, at diagnosis | Completed today | Seen by Dr. Abernathy-Mensah today |
| Medication safety | Antiplatelet adherence and bleeding | Every visit | Completed today | Aspirin starts today; no history of ulcer or bleeding; avoid NSAIDs |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | Atorvastatin starts today; report muscle pain |
| Self-management | Stroke warning signs (BE FAST) and calling 911 | At diagnosis, then every visit | Completed today | Taught; he repeated the signs back |
| Survey | Depression screen (PHQ-9) | Annually | Up to date | PHQ-9 7 at intake; mood reviewed today |
| Self-management | Re-entry social needs: housing, income, benefits, records | Every visit until settled | Completed today | Room by the week; benefits applications started; records requested |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026); 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024); Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease (AbuRahma AF, et al. J Vasc Surg 2022;75(1S):4S-22S) (2021); European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease (Naylor R, et al. Eur J Vasc Endovasc Surg 2023;65:7-111) (2023); 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018)
Follow-up: Preventive examination in two weeks. Hypertension review in four weeks, with electrolytes and creatinine and the echocardiogram. Next scheduled visit 2026-08-04: initial preventive physical examination (Welcome to Medicare). [S]